Ultrasound measurement of congenital cystic adenomatoid malformation volume ratio in prenatal evaluation on prognosis in fetus with congenital pulmonary sequestrations
10.13929/j.1672-8475.201707023
- VernacularTitle:产前超声测量肺头比值评价先天性肺隔离症胎儿预后
- Author:
Peng AN
1
;
Yu WANG
;
Yingjian YE
;
Wei FENG
;
Sufen ZHOU
;
Lan YU
Author Information
1. 湖北医药学院附属襄阳市第一人民医院超声影像科
- Keywords:
Bronchopulmonary sequestration;
Ultrasonography;
Pregnancy trimester,second;
Prognosis
- From:
Chinese Journal of Interventional Imaging and Therapy
2017;14(11):677-680
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the value of cystic adenomatoid malformation volume ratio (CVR) using prenatal ultrasound in evaluation of congenital pulmonary sequestrations (PS) prognosis in fetus.Methods Totally 88 cases of fetal PS diagnosed with prenatal ultrasound were enrolled.The fetal CVR were recorded,and the clinical outcomes were observed.The fetus were further divided into CVR≥1.6 group and CVR＜1.6 group,then the fetal hydrops rate,incidence of respiratory distress symptoms after birth and perinatal infant survival rate between two groups were compared.Results In 88 cases,prenatal ultrasound diagnosed intralobar pulmonary sequestration (ILS) type in 62 cases (62/88,70.45％),extralobar pulmonary sequestration (ELS) type I in 19 cases (19/88,21.59％),and ELS type Ⅱ in 7 cases (7/88,7.95％).There were 81 (81/88,92.05％) live births,5 (5/88,5.68％) of induction,and 2 (2/88,2.27％) of intrauterine fetal death,respectively.In 44 cases of CVR≥1.6 group,36 cases (36/44,81.82％) had respiratory symptoms after birth,and 39 (39/44,88.64％) had combined fetal hydrops.The live birth rate was 84.09％ (37/44).In 44 cases of CVR＜1.6 group,3 cases (3/44,6.82％) had respiratory symptoms after birth and 3 (3/44,6.82％) had combined fetal hydrops.The live birth rate was 100％ (44/44).The fetal hydrops rate,incidence of respiratory symptoms after birth and perinatal infant survival rate were statistically different between the two groups (all P＜0.05).Conclusion Prenatal ultrasound CVR is an effective index for screening and assessing the prognosis in fetus with PS.
